Research and Development Infrastructure Investment Expected to Create Hundreds of U.S. Jobs Amgen announced plans to invest more than ...
According to recent statistics, the WHO (World Health Organization) has conducted an assessment of mpox cases in Africa, which showed that, as of 2...
New Jersey at a Glance – Often dubbed the “Medicine Chest of the World,” New Jersey has a rich legacy and a dynamic present as a global h...
Ryvu to support BioNTech in the acceleration of site activation and enrollment of patients for multiple of BioNTech’s priority oncology clin...
Boehringer Ingelheim announced that China’s National Medical Products Administration (NMPA) has approved HERNEXEOS® (zongertinib tablets)...
Phase III trial informed by comprehensive KARDIA data set generated through three Phase II studies: KARDIA-1, KARDIA-2 and KARDIA-3 In the Phase II KA...
Zai Lab announced the Hong Kong Department of Health has approved TIVDAK (tisotumab vedotin-tftv) in Hong Kong for the treatment of adult patients with r...
Foresight Diagnostics ("Foresight") announced that it has entered into a limited licensing agreement with Roche Molecular Systems and Roche Sequencing Sy...
Piramal Pharma Solutions extended its robust CDMO capabilities to George Medicines to develop WIDAPLIK. WIDAPLIK is the first and only FDA-approved tr...
BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biotechnology company focused on the design and development of small molecule medicines ...
-PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free injection technology, announ...
RemeGen Co., Ltd, a leading Chinese biopharmaceutical company, announced today that it has entered into an agreement with Santen Pharmaceutical (China) C...
Alignment follows Type C meeting for VYD2311 as previously disclosed BLA pathway for VYD2311 to be supported by a single, Phase 2/3 randomized, doubl...
Philips, a global leader in health technology,announced a plan for new investments of more than USD 150 million in U.S. manufacturi...
© 2025 Biopharma Boardroom. All Rights Reserved.
